For research use only. Not for therapeutic Use.
Mesoridazine-d3 is a deuterated form of mesoridazine, an antipsychotic medication used to treat schizophrenia. In this compound, three hydrogen atoms are replaced with deuterium, which enhances its utility in pharmacokinetic and metabolic studies. The deuterium labeling allows for precise tracking and analysis using mass spectrometry and NMR spectroscopy, facilitating research into the drug’s absorption, distribution, metabolism, and excretion. Despite the isotopic substitution, mesoridazine-d3 retains the pharmacological properties of the non-deuterated drug, making it valuable for research and clinical studies.
| Catalog Number | R059621 |
| CAS Number | NA |
| Synonyms | 10-[2-(1-(Methyl-d3)-2-piperidinyl)ethyl]-2-(methylsulfinyl)phenothiazine; 1-(Methyl-d3)-2-[2-[2-(methylsulfinyl)phenothiazin-10-yl]ethyl]piperidine; 10-[2-(1-(Methyl-d3)-2-piperidyl)ethyl]-2-(methylsulfinyl)phenothiazine; NSC 186066-d3; Serentil-d3; |
| Molecular Formula | C₂₁H₂₃D₃N₂OS₂ |
| Purity | ≥95% |
| Storage | -20°C |
